Becton, Dickinson and Co. | BDX - Umsatzerlöse

Aktienkurs
144.48
Täglich Wechseln
0.30 0.21%
Monatlich
-7.10%
Jährlich
-16.13%
Q2 Prognose
146.34




Der Umsatz Veränderung Datum
Abbott USD 11.16B 300M 2026-03
Agilent USD 1.8B 63M 2025-12
Align Technology USD 1.04B 10M 2026-03
AngioDynamics USD 79.43M 3.72M 2025-09
Avanos Medical USD 182.2M 1.3M 2026-03
Baxter International USD 2.7B 270M 2026-03
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Bio-Rad Laboratories USD 592.1M 101.1M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
Cooper Companies USD 1.02B 41.1M 2025-12
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 880M 81M 2026-03
Dexcom USD 1.19B 70M 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Globus Medical USD 759.85M 66.55M 2026-03
Insulet USD 761.7M 22.1M 2026-03
Integra LifeSciences USD 391.9M 43M 2026-03
Intuitive Surgical USD 2.77B 100M 2026-03
J&J USD 24.1B 500M 2026-03
Masimo USD 403.6M 8.9M 2026-03
Medtronic USD 9B 39M 2026-01
Solventum Corp USD 2.01B 20M 2026-03
Stryker USD 6B 1.2B 2026-03
Tandem Diabetes Care USD 247.22M 43.18M 2026-03
Teleflex USD 548.3M 20.68M 2026-03
Terumo JPY 296.63B 21.66B 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03